In October, DeLauro asked the FDA to provide an update within the week on the status of the development of the breast density notification rule. The FDA’s response arrived shortly after, acknowledging that the Mammography Quality Standards Act (MQSA) final rule would publish before the end of the 2022 calendar year or early 2023.
DeLauro and Fitzpatrick previously worked together on the Breast Density and Mammography Reporting Act that directs the Food and Drug Administration (FDA) to issue a nationwide reporting standard to require all mammography reports to include an assessment of breast density. This policy change was included in the Fiscal Year 2020 Consolidated Appropriations Act and is expected to be released by the end of this year or early next year.
Back to HCB News
Ad Statistics
Times Displayed: 2872
Times Visited: 27 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
